Insider · CIK 0001757584
James David Clark
Files at CVS (CVS HEALTH Corp). First filing Mar 7, 2025, latest Mar 7, 2025.
In brief
James David Clark files SEC Form 4 as officer at CVS (CVS HEALTH Corp). Since Mar 7, 2025, James David Clark has reported 0 open-market buys worth $0 and 1 open-market sell worth $498k, the latest filed on Mar 7, 2025.
A track record needs three past buys with six months of prices behind them; James David Clark has 0, so none is measured yet.
The newest scored trade: sold $498k of CVS on Mar 5, 2025, filed Mar 7, 2025, scored 28 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CVS: CVS HEALTH Corp
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 5, 2025 | CVS CVS HEALTH Corp | 7,513 0.00% of outstanding | $498k | Mar 5, 2025 | none |
Transactions
Every row this insider has filed, 13 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 26, 2026 | CVS CVS HEALTH Corp | FTax withholding Common Stock (Restricted) | -454 | $90.98 | $41k | 27,606 | Jun 29, 2026 |
| Mar 31, 2026 | CVS CVS HEALTH Corp | AGrant or award Common Stock (Restricted) | +11,138 | $71.82 | $800k | 35,539 | Apr 2, 2026 |
| Apr 1, 2026 | CVS CVS HEALTH Corp | FTax withholding Common Stock | -3,262 | $72.49 | $236k | 15,457 | Apr 2, 2026 |
| Mar 31, 2026 | CVS CVS HEALTH Corp | AGrant or award Stock Optionderivative | +11,976 | $71.82 | $860k | 11,976 | Apr 2, 2026 |
| Dec 1, 2025 | CVS CVS HEALTH Corp | FTax withholding Common Stock (Restricted) | -220 | $79.10 | $17k | 24,401 | Dec 2, 2025 |
| Apr 1, 2025 | CVS CVS HEALTH Corp | FTax withholding Common Stock | -2,266 | $67.98 | $154k | 11,240 | Apr 3, 2025 |
| Apr 1, 2025 | CVS CVS HEALTH Corp | AGrant or award Common Stock (Restricted) | +14,710 | $67.98 | $1000k | 24,707 | Apr 3, 2025 |
| Mar 5, 2025 | CVS CVS HEALTH Corp | MOption exercise Common Stock | +7,513 | $62.21 | $467k | 15,907 | Mar 7, 2025 |
| Mar 5, 2025 | CVS CVS HEALTH Corp | SOpen-market sale Common Stock | -7,513 | $66.35 | $498k | 8,394 | Mar 7, 2025 |
| Mar 5, 2025 | CVS CVS HEALTH Corp | MOption exercise Stock Optionderivative | -7,513 | $0.00 | $0 | 0 | Mar 7, 2025 |
| Nov 30, 2024 | CVS CVS HEALTH Corp | FTax withholding Common Stock | -86 | $59.85 | $5,147 | 8,394 | Dec 3, 2024 |
| Feb 12, 2024 | CVS CVS HEALTH Corp | AGrant or award Common Stock | +2,452 | $0.00 | $0 | 7,150 | Feb 14, 2024 |
| Dec 14, 2023 | CVS CVS HEALTH Corp | FTax withholding Common Stock (Restricted) | -122 | $68.48 | $8,355 | 8,760 | Dec 15, 2023 |
Questions about James David Clark
Answered from the filings on this page, as of the latest one.
Is James David Clark buying or selling?
Not in the last 12 months. James David Clark's latest open-market trade on SEC Form 4 was sold $498k of CVS on Mar 5, 2025.
How did James David Clark's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and James David Clark has 0.
Where does James David Clark file Form 4?
James David Clark has filed Form 4 at CVS (CVS HEALTH Corp) as SVP, Cont & Chief Acct Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.